Terms: = Germ cell tumor AND CD74, ENSG00000019582, 972, protein 41, Ia-GAMMA, HLADG, DHLAG AND Prognosis
11 results:
1. Tozasertib activates anti-tumor immunity through decreasing regulatory T cells in melanoma.
Wang Q; Liu W; Zhou H; Lai W; Hu C; Dai Y; Li G; Zhang R; Zhao Y
Neoplasia; 2024 Feb; 48():100966. PubMed ID: 38237304
[TBL] [Abstract] [Full Text] [Related]
2. prognosis of CDKN2A germline mutation in patients with familial melanoma: a systematic review and meta-analysis.
Taibo A; Paradela S; Suanzes-Hernández J; Balboa-Barreiro V; Amado-Bouza J; Fonseca E
Melanoma Res; 2024 Feb; 34(1):9-15. PubMed ID: 37924530
[TBL] [Abstract] [Full Text] [Related]
3. An
Özbek M; Toy HI; Oktay Y; Karakülah G; Suner A; Pavlopoulou A
PeerJ; 2023; 11():e15096. PubMed ID: 36945359
[TBL] [Abstract] [Full Text] [Related]
4. Identification of fatty acid metabolism-related molecular subtype biomarkers and their correlation with immune checkpoints in cutaneous melanoma.
Xu Y; Chen Y; Jiang W; Yin X; Chen D; Chi Y; Wang Y; Zhang J; Zhang Q; Han Y
Front Immunol; 2022; 13():967277. PubMed ID: 36466837
[TBL] [Abstract] [Full Text] [Related]
5. tumor response evaluation in patients with malignant melanoma undergoing immune checkpoint inhibitor therapy and prognosis prediction using
Kitajima K; Watabe T; Nakajo M; Ishibashi M; Daisaki H; Soeda F; Tanemura A; Kanekura T; Yamazaki N; Ito K
Jpn J Radiol; 2022 Jan; 40(1):75-85. PubMed ID: 34287739
[TBL] [Abstract] [Full Text] [Related]
6. Obesity is not associated with disease-free interval, melanoma-specific survival, or overall survival in patients with clinical stage IB-II melanoma after SLNB.
Deckers EA; Kruijff S; Bastiaannet E; van Ginkel RJ; Hoekstra-Weebers JEHM; Hoekstra HJ
J Surg Oncol; 2021 Sep; 124(4):655-664. PubMed ID: 34085291
[TBL] [Abstract] [Full Text] [Related]
7. Glioblastoma Myeloid-Derived Suppressor cell Subsets Express Differential Macrophage Migration Inhibitory Factor Receptor Profiles That Can Be Targeted to Reduce Immune Suppression.
Alban TJ; Bayik D; Otvos B; Rabljenovic A; Leng L; Jia-Shiun L; Roversi G; Lauko A; Momin AA; Mohammadi AM; Peereboom DM; Ahluwalia MS; Matsuda K; Yun K; Bucala R; Vogelbaum MA; Lathia JD
Front Immunol; 2020; 11():1191. PubMed ID: 32625208
[TBL] [Abstract] [Full Text] [Related]
8. Automated glioma grading on conventional MRI images using deep convolutional neural networks.
Zhuge Y; Ning H; Mathen P; Cheng JY; Krauze AV; Camphausen K; Miller RW
Med Phys; 2020 Jul; 47(7):3044-3053. PubMed ID: 32277478
[TBL] [Abstract] [Full Text] [Related]
9. Diagnostic accuracy of circulating-free DNA for the determination of MYCN amplification status in advanced-stage neuroblastoma: a systematic review and meta-analysis.
Trigg RM; Turner SD; Shaw JA; Jahangiri L
Br J Cancer; 2020 Mar; 122(7):1077-1084. PubMed ID: 32015512
[TBL] [Abstract] [Full Text] [Related]
10. cd74 regulates complexity of tumor cell HLA class II peptidome in brain metastasis and is a positive prognostic marker for patient survival.
Zeiner PS; Zinke J; Kowalewski DJ; Bernatz S; Tichy J; Ronellenfitsch MW; Thorsen F; Berger A; Forster MT; Muller A; Steinbach JP; Beschorner R; Wischhusen J; Kvasnicka HM; Plate KH; Stefanović S; Weide B; Mittelbronn M; Harter PN
Acta Neuropathol Commun; 2018 Mar; 6(1):18. PubMed ID: 29490700
[TBL] [Abstract] [Full Text] [Related]
11. Acral (volar-subungual) melanoma in Auckland, New Zealand.
Shaw JH; Koea JB
Br J Surg; 1988 Jan; 75(1):69-72. PubMed ID: 3337957
[TBL] [Abstract] [Full Text] [Related]
